Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders
Само за регистроване кориснике
2023
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece, 2023, 125-125Издавач:
- European Research Network on Signal Transduction CA18133 (ERNEST)
Финансирање / пројекти:
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200161 (Универзитет у Београду, Фармацеутски факултет) (RS-MESTD-inst-2020-200161)
Институција/група
PharmacyTY - CONF AU - Nikolić, Katarina AU - Radan, Milica AU - Đikić, Teodora PY - 2023 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4762 PB - European Research Network on Signal Transduction CA18133 (ERNEST) C3 - 8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece T1 - Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders SP - 125 EP - 125 UR - https://hdl.handle.net/21.15107/rcub_farfar_4762 ER -
@conference{ author = "Nikolić, Katarina and Radan, Milica and Đikić, Teodora", year = "2023", publisher = "European Research Network on Signal Transduction CA18133 (ERNEST)", journal = "8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece", title = "Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders", pages = "125-125", url = "https://hdl.handle.net/21.15107/rcub_farfar_4762" }
Nikolić, K., Radan, M.,& Đikić, T.. (2023). Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders. in 8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece European Research Network on Signal Transduction CA18133 (ERNEST)., 125-125. https://hdl.handle.net/21.15107/rcub_farfar_4762
Nikolić K, Radan M, Đikić T. Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders. in 8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece. 2023;:125-125. https://hdl.handle.net/21.15107/rcub_farfar_4762 .
Nikolić, Katarina, Radan, Milica, Đikić, Teodora, "Polypharmacological strategy in rational drug design of new dual 5HT2A/D2-R antagonists as potentially effective therapeutics of complex neurological and mental disorders" in 8th and final ERNEST Meeting "GPCR structure and function: The present and perspectives for the future”, May 3-7, 2023 in Crete, Greece (2023):125-125, https://hdl.handle.net/21.15107/rcub_farfar_4762 .